
Laboratorios Rubio
Pharmaceutical solutions specializing in niche therapeutic areas, enhancing patient care with tailored treatments.
Date | Investors | Amount | Round |
---|---|---|---|
* | €4.0m | Debt | |
Total Funding | 000k |
EUR | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | 22 % |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
% profit margin | 5 % | 5 % |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Laboratorios Rubio operates in the pharmaceutical industry, focusing on developing and manufacturing specialized medications for niche therapeutic areas. The company serves healthcare professionals and patients by providing tailored treatments that address specific medical needs. Operating primarily in the European market, Laboratorios Rubio employs a business model centered around research and development, production, and distribution of pharmaceutical products. Revenue is generated through the sale of these specialized medications to healthcare providers and institutions. The company is committed to maintaining compliance with data protection laws, ensuring responsible handling of personal information. Key aspects of their operations include a focus on patient care, adherence to regulatory standards, and a commitment to quality in pharmaceutical manufacturing.
Keywords: pharmaceuticals, niche, therapeutic, patient care, healthcare, European market, R&D, compliance, manufacturing, quality.
Tech stack
Investments by Laboratorios Rubio
Edit